• Je něco špatně v tomto záznamu ?

The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases

I. Dovinova, M. Kvandová, P. Balis, L. Gresova, M. Majzunova, L. Horakova, J. Y. Chan, M. Barancik

. 2020 ; 69 (Suppl 4) : S541-S553. [pub] 20201231

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21028111

Reactive oxygen species are an important element of redox regulation in cells and tissues. During physiological processes, molecules undergo chemical changes caused by reduction and oxidation reactions. Free radicals are involved in interactions with other molecules, leading to oxidative stress. Oxidative stress works two ways depending on the levels of oxidizing agents and products. Excessive action of oxidizing agents damages biomolecules, while a moderate physiological level of oxidative stress (oxidative eustress) is necessary to control life processes through redox signaling required for normal cellular operation. High levels of reactive oxygen species (ROS) mediate pathological changes. Oxidative stress helps to regulate cellular phenotypes in physiological and pathological conditions. Nrf2 (nuclear factor erythroid 2-related factor 2, NFE2L2) transcription factor functions as a target nuclear receptor against oxidative stress and is a key factor in redox regulation in hypertension and cardiovascular disease. Nrf2 mediates transcriptional regulation of a variety of target genes. The Keap1-Nrf2-ARE system regulates many detoxification and antioxidant enzymes in cells after the exposure to reactive oxygen species and electrophiles. Activation of Nrf2/ARE signaling is differentially regulated during acute and chronic stress. Keap1 normally maintains Nrf2 in the cytosol and stimulates its degradation through ubiquitination. During acute oxidative stress, oxidized molecules modify the interaction of Nrf2 and Keap1, when Nrf2 is released from the cytoplasm into the nucleus where it binds to the antioxidant response element (ARE). This triggers the expression of antioxidant and detoxification genes. The consequence of long-term chronic oxidative stress is activation of glycogen synthase kinase 3beta (GSK-3beta) inhibiting Nrf2 activity and function. PPARgamma (peroxisome proliferator-activated receptor gamma) is a nuclear receptor playing an important role in the management of cardiovascular diseases, hypertension and metabolic syndrome. PPARgamma targeting of genes with peroxisome proliferator response element (PPRE) has led to the identification of several genes involved in lipid metabolism or oxidative stress. PPARgamma stimulation is triggered by endogenous and exogenous ligands - agonists and it is involved in the activation of several cellular signaling pathways involved in oxidative stress response, such as the PI3K/Akt/NOS pathway. Nrf2 and PPARgamma are linked together with their several activators and Nrf2/ARE and PPARgamma/PPRE pathways can control several types of diseases.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21028111
003      
CZ-PrNML
005      
20211206150411.0
007      
ta
008      
211105s2020 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934612 $2 doi
035    __
$a (PubMed)33656904
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Dovinová, Ima $7 xx0076654 $u Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovak Republic $u Intitute of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology in Bratislava, Bratislava, Slovak Republic
245    14
$a The role of Nrf2 and PPARgamma in the improvement of oxidative stress in hypertension and cardiovascular diseases / $c I. Dovinova, M. Kvandová, P. Balis, L. Gresova, M. Majzunova, L. Horakova, J. Y. Chan, M. Barancik
504    __
$a Literatura
520    9_
$a Reactive oxygen species are an important element of redox regulation in cells and tissues. During physiological processes, molecules undergo chemical changes caused by reduction and oxidation reactions. Free radicals are involved in interactions with other molecules, leading to oxidative stress. Oxidative stress works two ways depending on the levels of oxidizing agents and products. Excessive action of oxidizing agents damages biomolecules, while a moderate physiological level of oxidative stress (oxidative eustress) is necessary to control life processes through redox signaling required for normal cellular operation. High levels of reactive oxygen species (ROS) mediate pathological changes. Oxidative stress helps to regulate cellular phenotypes in physiological and pathological conditions. Nrf2 (nuclear factor erythroid 2-related factor 2, NFE2L2) transcription factor functions as a target nuclear receptor against oxidative stress and is a key factor in redox regulation in hypertension and cardiovascular disease. Nrf2 mediates transcriptional regulation of a variety of target genes. The Keap1-Nrf2-ARE system regulates many detoxification and antioxidant enzymes in cells after the exposure to reactive oxygen species and electrophiles. Activation of Nrf2/ARE signaling is differentially regulated during acute and chronic stress. Keap1 normally maintains Nrf2 in the cytosol and stimulates its degradation through ubiquitination. During acute oxidative stress, oxidized molecules modify the interaction of Nrf2 and Keap1, when Nrf2 is released from the cytoplasm into the nucleus where it binds to the antioxidant response element (ARE). This triggers the expression of antioxidant and detoxification genes. The consequence of long-term chronic oxidative stress is activation of glycogen synthase kinase 3beta (GSK-3beta) inhibiting Nrf2 activity and function. PPARgamma (peroxisome proliferator-activated receptor gamma) is a nuclear receptor playing an important role in the management of cardiovascular diseases, hypertension and metabolic syndrome. PPARgamma targeting of genes with peroxisome proliferator response element (PPRE) has led to the identification of several genes involved in lipid metabolism or oxidative stress. PPARgamma stimulation is triggered by endogenous and exogenous ligands - agonists and it is involved in the activation of several cellular signaling pathways involved in oxidative stress response, such as the PI3K/Akt/NOS pathway. Nrf2 and PPARgamma are linked together with their several activators and Nrf2/ARE and PPARgamma/PPRE pathways can control several types of diseases.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidační responzivní elementy $7 D061745
650    12
$a krevní tlak $7 D001794
650    _2
$a kardiovaskulární nemoci $x metabolismus $x patofyziologie $7 D002318
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x metabolismus $x patofyziologie $7 D006973
650    _2
$a KEAP-1 $x metabolismus $7 D000072019
650    _2
$a faktor 2 související s NF-E2 $x metabolismus $7 D051267
650    12
$a oxidační stres $7 D018384
650    _2
$a PPAR gama $x metabolismus $7 D047495
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    _2
$a signální transdukce $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Kvandová, Miroslava $7 _AN112288 $u Center for Cardiology, Cardiology I, Medical Center of the Johannes Gutenberg-Universität Mainz, Germany
700    1_
$a Bališ, Peter $7 xx0198090 $u Centre of Experimental Medicine, Slovak Academy Of Sciences, Bratislava, Slovak Republic
700    1_
$a Grešová, Linda, $d 1986- $7 xx0267155 $u Centre of Experimental Medicine, Slovak Academy Of Sciences, Bratislava, Slovak Republic
700    1_
$a Majzúnová, Miroslava, $d 1986- $7 xx0267157 $u Centre of Experimental Medicine, Slovak Academy Of Sciences, Bratislava, Slovak Republic $u Department of Animal Physiology and Ethology, Faculty of Natural Sciences, Bratislava, Slovak Republic,
700    1_
$a Horáková, Ľubica $7 xx0076549 $u Centre of Experimental Medicine, Slovak Academy Of Sciences, Bratislava, Slovak Republic
700    1_
$a Chan, J. Y. H. $u Institute for Translational Research in Biomedicine, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
700    1_
$a Barančík, Miroslav $7 xx0089695 $u Centre of Experimental Medicine, Slovak Academy Of Sciences, Bratislava, Slovak Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, Suppl 4 (2020), s. S541-S553
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33656904 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20211105 $b ABA008
991    __
$a 20211206150411 $b ABA008
999    __
$a ok $b bmc $g 1728724 $s 1148656
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c Suppl 4 $d S541-S553 $e 20201231 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20211105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...